Objective: To summarize evidence and data in relation to the implications of autophagy in periodontal disease (PD) and describe potential nutraceuticals or pharmaceuticals able to modulate this subtype of cell death. Design: Literature searches of different electronic databases (Medline via PubMed, SCOPUS, Web of Science, and EMBASE) using appropriate keywords (e.g. periodontal disease, periodontitis, alveolar bone loss, periodontal infection, tooth loss, autophagy, programmed cell death, type 2 cell death) were performed. Then, a comprehensive literature review of the current understanding of this link was elaborated. Results: Autophagy plays a pivotal role in PD and it seems that its regulation may be an interesting avenue for future periodontal research according to several in vivo and in vitro reports. Conclusion: Nowadays research has ascertained the role of autophagy in PD, specially its role in the host defence against periodontal disease drivers. A bulk of research has recognized several pharmaceuticals and nutraceuticals that can potentially modulate this kind of cell death and serve as useful therapies. However, further research is warranted in order to reach a clinical translation, which could be of help in the discovery of novel host modulation therapies for PD.